• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$0.56 -$0.02 (-3.00%)

REAL-TIME: Last trade at

Peregrine Pharmaceuticals

NASDAQ:PPHM

US STOCK FUTURES: HOT STOCKS TO WATCH

7 Reasons to Worry About Next Week

Avoid This Biotech Stock

Peregrine Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Peregrine Pharma's Secret Weapon

A Simplified ASCO 2011 List for Biotech Investor Research

3 Biotechs With Momentum Ahead of ASCO

20 Stocks Under $3 With Significant Insider Buying

Peregrine Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Peregrine Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Trial News Make Peregrine Pharmaceuticals Worth Watching

Peregrine Pharmaceuticals CEO Discusses F2Q2011 Results – Earnings Call Transcript

Peregrine Pharmaceuticals CEO Discusses F2Q2011 Results – Earnings Call Transcript

Peregrine Reports Positive Interim Survival Data From Brain Cancer Drug Study

Peregrine Pharmaceuticals CEO Discusses F1Q2011 Results - Earnings Call Transcript

Peregrine Pharmaceuticals CEO Discusses F1Q2011 Results - Earnings Call Transcript

Peregrine Pharmaceuticals, Inc. F4Q10 (Qtr End 04/30/10) Earnings Call Transcript

Peregrine Pharmaceuticals, Inc. F4Q10 (Qtr End 04/30/10) Earnings Call Transcript

Peregrine drug shows promise against breast cancer

UPDATE 1-Peregrine Pharma lung cancer trial shows promise

UPDATE 1-Peregrine's brain cancer agent shows promise, shrs up